JP2009514894A5 - - Google Patents

Download PDF

Info

Publication number
JP2009514894A5
JP2009514894A5 JP2008539114A JP2008539114A JP2009514894A5 JP 2009514894 A5 JP2009514894 A5 JP 2009514894A5 JP 2008539114 A JP2008539114 A JP 2008539114A JP 2008539114 A JP2008539114 A JP 2008539114A JP 2009514894 A5 JP2009514894 A5 JP 2009514894A5
Authority
JP
Japan
Prior art keywords
membered
ring
cor
compound
nitrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008539114A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009514894A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/043269 external-priority patent/WO2007056330A1/en
Publication of JP2009514894A publication Critical patent/JP2009514894A/ja
Publication of JP2009514894A5 publication Critical patent/JP2009514894A5/ja
Pending legal-status Critical Current

Links

JP2008539114A 2005-11-07 2006-11-06 ジャイレース阻害剤としてのベンズイミダゾール誘導体 Pending JP2009514894A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73413905P 2005-11-07 2005-11-07
PCT/US2006/043269 WO2007056330A1 (en) 2005-11-07 2006-11-06 Benzimidazole derivatives as gyrase inhibitors

Publications (2)

Publication Number Publication Date
JP2009514894A JP2009514894A (ja) 2009-04-09
JP2009514894A5 true JP2009514894A5 (cg-RX-API-DMAC7.html) 2009-10-22

Family

ID=37894258

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008539114A Pending JP2009514894A (ja) 2005-11-07 2006-11-06 ジャイレース阻害剤としてのベンズイミダゾール誘導体

Country Status (7)

Country Link
US (1) US8394803B2 (cg-RX-API-DMAC7.html)
EP (1) EP1948635A1 (cg-RX-API-DMAC7.html)
JP (1) JP2009514894A (cg-RX-API-DMAC7.html)
CN (1) CN101321744A (cg-RX-API-DMAC7.html)
AU (1) AU2006311729A1 (cg-RX-API-DMAC7.html)
CA (1) CA2626685A1 (cg-RX-API-DMAC7.html)
WO (1) WO2007056330A1 (cg-RX-API-DMAC7.html)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR042956A1 (es) 2003-01-31 2005-07-13 Vertex Pharma Inhibidores de girasa y usos de los mismos
US8404852B2 (en) 2003-01-31 2013-03-26 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
US7582641B2 (en) 2003-01-31 2009-09-01 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
US8193352B2 (en) 2003-01-31 2012-06-05 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
US7618974B2 (en) 2003-01-31 2009-11-17 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
US7569591B2 (en) 2003-01-31 2009-08-04 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
AR069599A1 (es) 2007-12-07 2010-02-03 Vertex Pharma Forma cristalina de 1- etil-1-3-(5-(5- fluoropiridin -3-il)-7- (pirimidin-2-il)-1h-benzo (d) imidazol -2-il) urea
WO2010027583A1 (en) 2008-09-03 2010-03-11 Universal Display Corporation Phosphorescent materials
GB0821913D0 (en) 2008-12-02 2009-01-07 Price & Co Antibacterial compounds
WO2010111058A1 (en) * 2009-03-23 2010-09-30 Merck Sharp & Dohme Corp. P2x3, receptor antagonists for treatment of pain
US9221765B2 (en) 2009-06-10 2015-12-29 North Carolina State University Inhibition and dispersion of bacterial biofilms with benzimidazole derivatives
EP2552893B1 (en) 2010-03-31 2014-10-29 Actelion Pharmaceuticals Ltd. Antibacterial isoquinolin-3-ylurea derivatives
WO2011151620A1 (en) 2010-06-01 2011-12-08 Summit Corporation Plc Compounds for the treatment of clostridium difficile associated disease
CA2801274C (en) 2010-06-01 2021-06-15 Summit Corporation Plc Compounds for the treatment of clostridium difficile-associated disease
WO2011151619A1 (en) 2010-06-01 2011-12-08 Summit Corporation Plc Compounds for the treatment of clostridium difficile associated disease
WO2011151617A1 (en) 2010-06-01 2011-12-08 Summit Corporation Plc Compounds for the treatment of clostridium difficile associated disease
WO2011151618A2 (en) 2010-06-01 2011-12-08 Summit Corporation Plc Compounds for the treatment of clostridium difficile-associated disease
KR101882172B1 (ko) * 2011-01-14 2018-07-26 스페로 트리넴, 인코포레이티드 자이라제 및 토포이소머라제 ⅳ 억제제의 제조방법
MX341342B (es) 2011-01-14 2016-08-17 Vertex Pharma Formas solidas del inhibidor de girasa (r)-1-etil-3-[6-fluoro-5-[2 -(1-hidroxi-1-metil-etil) pirimidin-5-il]-7-(tetrahidrofuran-2-il) -1h-benzimidazol-2-il]urea.
JP6085829B2 (ja) 2011-01-14 2017-03-01 スペロ トリネム, インコーポレイテッド ピリミジンジャイレースおよびトポイソメラーゼiv阻害剤
US8481552B2 (en) 2011-01-14 2013-07-09 Vertex Pharmaceuticals Incorporated Solid forms of gyrase inhibitor (R)-1-ethyl-3-[5-[2-(1-hydroxy-1-methyl-ethyl)pyrimidin-5-YL]-7-(tetrahydrofuran-2-yl)-1H-benzimidazol-2-YL]urea
AR088729A1 (es) 2011-03-29 2014-07-02 Actelion Pharmaceuticals Ltd Derivados de 3-ureidoisoquinolin-8-ilo y una composicion farmaceutica
ES2576298T3 (es) * 2011-06-20 2016-07-06 Vertex Pharmaceuticals Incorporated Ésteres de fosfato de inhibidores de girasa y topoisomerasa
US9572809B2 (en) 2012-07-18 2017-02-21 Spero Trinem, Inc. Combination therapy to treat Mycobacterium diseases
US9018216B2 (en) 2012-07-18 2015-04-28 Vertex Pharmaceuticals Incorporated Solid forms of (R)-2-(5-(2-(3-ethylureido)-6-fluoro-7-(tetrahydrofuran-2-yl)-1H-benzo[d]imidazol-5-yl)pyrimidin-2-yl)propan-2-yl dihydrogen phosphate and salts thereof
US9079935B2 (en) 2012-08-13 2015-07-14 The Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Vegas Reducing risk of contracting Clostridium-difficile associated disease
SG11201606332PA (en) 2014-02-03 2016-09-29 Spero Gyrase Inc Antibacterial combinations comprising polymyxin
CN104945329B (zh) * 2014-03-24 2017-09-01 中国医学科学院医药生物技术研究所 抗结核药物
US20180000793A1 (en) 2015-02-06 2018-01-04 Ernesto Abel-Santos Inhibiting Germination of Clostridium Perfringens Spores to Reduce Necrotic Enteritis
RU2019133662A (ru) 2017-03-24 2021-04-26 Тайсо Фармасьютикал Ко., Лтд. Производное 2(1h)-хинолинона
JP7730803B2 (ja) 2019-07-17 2025-08-28 サミット (オックスフォード) リミティド リジニラゾールの調製方法およびその結晶形態
CN111658646B (zh) * 2020-06-28 2021-03-02 河南工业大学 2,6-双(2-苯并咪唑基)吡啶在制备耐碳青霉烯类铜绿假单胞菌感染药物中的应用
GB202100470D0 (en) 2021-01-14 2021-03-03 Summit Oxford Ltd Solid tablet dosage for of ridinilazole
GB202100471D0 (en) 2021-01-14 2021-03-03 Summit Oxford Ltd Preparation of antibacterial compounds
US12220421B2 (en) 2021-09-09 2025-02-11 The Boards Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Inhibitors of C. difficile spore germination

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL362691A1 (en) 2000-12-15 2004-11-02 Vertex Pharmaceuticals Incorporated Bacterial gyrase inhibitors and uses thereof
AU2003245442B2 (en) 2002-06-13 2009-02-05 Vertex Pharmaceuticals Incorporated 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase IV inhibitors for the treatment of bacterial infections
US7582641B2 (en) 2003-01-31 2009-09-01 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
AR042956A1 (es) * 2003-01-31 2005-07-13 Vertex Pharma Inhibidores de girasa y usos de los mismos
US7569591B2 (en) * 2003-01-31 2009-08-04 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
US7618974B2 (en) 2003-01-31 2009-11-17 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof

Similar Documents

Publication Publication Date Title
CA2513463A1 (en) Gyrase inhibitors and uses thereof
JP2005533061A5 (cg-RX-API-DMAC7.html)
CA2577758A1 (en) Gyrase inhibitors and uses thereof
TW293817B (cg-RX-API-DMAC7.html)
CA2489128A1 (en) 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections
ES2675798T3 (es) Compuestos antimicrobianos y métodos para fabricar y usar los mismos
ES2576298T3 (es) Ésteres de fosfato de inhibidores de girasa y topoisomerasa
CN111566099B (zh) 抗菌化合物
JP2007514782A5 (cg-RX-API-DMAC7.html)
ES2705923T3 (es) Formas sólidas de inhibidor de girasa (R)-1-etil-3-[6-fluoro-5-[2-(1-hidroxi-1-metil-etil)pirimidin-5-il]-7-(tetrahidrofuran-2-il)-1H-bencimidazol-2-il]urea
AU2010224245B2 (en) Pyrrolo [2, 3-b] pyridine derivatives for the inhibition of Raf kinases
TW201033197A (en) Inhibitors of HCV NS5A
JP2009514894A (ja) ジャイレース阻害剤としてのベンズイミダゾール誘導体
WO2012096832A2 (en) Hdac inhibiting derivatives of camptothecin
CN1342163A (zh) 酮内酯类抗生素
JP2015514063A (ja) 抗菌化合物
US9399639B2 (en) Substituted azaindole compounds, salts, pharmaceutical compositions thereof and methods of use
JP2009539866A (ja) 置換エリスロマイシンアナログの調製および有用性
RU2013137750A (ru) Пиримидиновые ингибиторы гиразы и топоизомеразы iv
US20130281442A1 (en) Compounds for Treatment of Bovine Mastitis
CN113614092A (zh) 提供抗革兰氏阳性细菌增强的抗菌活性的组合物及其用途
EP1411949A2 (en) 8/17 heterocyclic compounds and uses thereof as d-alanyl-d-alanine ligase inhibitors
CA2797281A1 (en) Aza-indole derivatives useful as modulators of faah
RU2007121581A (ru) Макролоны-аминозамещенные хинолоны
TW201904970A (zh) 抗微生物劑及製造及使用方法